Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis [Yahoo! Finance]
Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements [Yahoo! Finance]
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements
Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain [Yahoo! Finance]